ASCO 2020 virtual annual meeting - day 3
Our live coverage from this year’s slimmed down, virtual version of the American Society of Clinical Oncology (ASCO) annual meeting continues at 8am (ET) as we move into the third and final day of the oncology event.
It follows our live coverage of ASCO 2020 day 1 and day 2, during which we’ve already featured Amgen’s Kyprolis, AstraZeneca’s Tagrisso, rare cancers and genomics, BCMA therapy, COVID-19’s impact on cancer patients and much more.
View all the live coverage of the virtual ASCO 2020, and day three live blog is below (please allow the blog a few moments to load):
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organisation. The Company, including a Contract Research Organisation (CRO) and Contract Commercial Organisation (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds, including 4,400 experts dedicated to oncology and haematology who collaborate with our customers to change the history of cancer treatments. We embrace our customers’ boldest visions and bring experience, innovation and our passion to every oncology program we run. Learn more at: https://www.syneoshealth.com/collaborate-for-a-cure.
